Filing Details

Accession Number:
0001209191-20-041644
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-08 12:30:41
Reporting Period:
2020-07-06
Accepted Time:
2020-07-08 12:30:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397266 K Matthew Fust C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-06 6,181 $21.00 19,731 No 4 M Direct
Common Stock Disposition 2020-07-06 6,181 $90.00 13,550 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-07-06 6,181 $0.00 6,181 $21.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-01-29 No 4 M Direct
Footnotes
  1. The exercise and sale reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The option vested with respect to 1/36th of the shares monthly from the grant date of January 29, 2014 such that option fully vested on the third anniversary of the grant date.